...Good morning. I'm Chris Boerner, Board Chair, and together with my fellow Directors, I want to welcome you to our 2025 Annual Meeting of Shareholders. We value the opportunity to speak with you at our annual meeting, to share our accomplishments with you, and to answer your questions. Like last year, we've made arrangements for you to submit questions both in advance and at today's meeting itself in an effort to preserve these valuable interactions. Before we officially call the meeting to order, I'd like to extend my warmest regards to our shareholders who have long supported our vision to transform patients' lives through science. I'd also like to update you on the recent General Counsel leadership transition we announced earlier today. After 33 years at Bristol-Myers Squibb, including the last 18 as General Counsel, Sandy Leung has decided to retire, effective today. Among a long list of accomplishments, Sandy has helped shape and guide the evolution of the law department, our compliance...
